| 1 | 101477-55-8 | 洛美利嗪 | Lomerizine | C27H32Cl2F2N2O3 | |
| 2 | 1022150-57-7 | 6-[[6-(1-甲基-1H-吡唑-4-基)-1,2,4-噻唑并[4,3-b]吡嗪-3-基]硫代]喹啉 | 6-((6-(1-methyl-1h-pyrazol-4-yl)-1,2,4-triazolo(4,3-b)pyridazin-3-yl)thio)quinoline | C18H13N7S | |
| 3 | 1028486-01-2 | 4-[[9-氯-7-(2-氟-6-甲氧基苯基)-5H-嘧啶并[5,4-d][2]苯并氮杂卓-2-基]氨基]-2-甲氧基苯甲酸 | 4-{[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid | C27H20ClFN4O4 | |
| 4 | 103639-04-9 | 盐酸蒽丹西酮二水合物 | Ondansetron hydrochloride dihydrate | C18H20ClN3O | |
| 5 | 105826-92-4 | 盐酸托烷司琼 | tropisetron hydrochloride | C17H21ClN2O2 | |
| 6 | 110221-44-8 | 盐酸替莫普利 | Temocapril hydrochloride | C23H28N2O5S2.ClH | |
| 7 | 115007-34-6 | 吗替麦考酚酯 | Mycophenolate mofetil | C23H31NO7 | |
| 8 | 1152311-62-0 | VX-661 | VX-661 | C26H27F3N2O6 | |
| 9 | 122647-32-9 | 富马酸伊布利特 | Ibutilide fumarate | (C20H36N2O3S)2.C4H4O4 | |
| 10 | 1268524-70-4 | (S)-(+)-2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮杂卓-6-基)乙酸叔丁酯 | (6s)-6-(2-Tert-butoxy-2-oxoethyl)-4-(4-chlorophenyl)-2,3,9-trimethyl-6,7-dihydrothieno[3,2-F][1,2,4]triazolo[4,3-A][1,4]diazepin-10-ium | C23H25ClN4O2S | |
| 11 | 132810-10-7 | 布南色林 | Blonanserin | C23H30FN3 | |
| 12 | 1374640-70-6 | 罗乐替尼 | CO-1686 | C27H28F3N7O3 | |
| 13 | 143664-11-3 | 依克立达 | ELACRIDAR | C34H33N3O5 | |
| 14 | 144143-96-4 | 甲磺酸依普罗沙坦 | Eprosartan mesylate | C24H28N2O7S2 | |
| 15 | 144675-97-8 | 马来到匹杉琼 | Benz(g)isoquinoline-5,10-dione, 6,9-bis((2-aminoethyl)amino)-, (2Z)-2- butenedioate (1:2) | C21H23N5O6 | |
| 16 | 150683-30-0 | 托伐普坦 | N-[4-(9-chloro-6-hydroxy-2-azabicyclo[5.4.0]undeca-8,10,12-triene-2-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide | C26H25ClN2O3 | |
| 17 | 157212-55-0 | 波生坦(一水合物) | Bosentan monohydrate | C27H31N5O7S | |
| 18 | 162635-04-3 | 西罗莫司脂化物 | Temsirolimus | C56H87NO16 | |
| 19 | 168273-06-1 | 利莫那班 | Rimonabant | C22H21Cl3N4O | |
| 20 | 172732-68-2 | 伐瑞拉迪 | Varespladib | C21H20N2O5 | |
| 21 | 177036-94-1 | 安倍生坦 | Ambrisentan | C22H22N2O4 | |
| 22 | 182349-12-8 | 富马酸卢帕他定 | Rupatadine fumarate | C26H26ClN3.C4H4O4 | |
| 23 | 193275-84-2 | 洛那法尼 | LONAFARNIB | C27H31Br2ClN4O2 | |
| 24 | 207679-81-0 | (R)-5-羟甲基托特罗定 | 2-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]-4-(hydroxymethyl)phenol | C22H31NO2 | |
| 25 | 212631-79-3 | 2-(2-氯-4-碘苯氨基)-N-(环丙基甲氧基)-3,4-二氟苯甲酰胺 | 2-(2-Chloro-4-iodophenylamino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide | C17H14ClF2IN2O2 | |
| 26 | 219580-11-7 | N-[2-[4-(二乙氨基)丁基]氨基-6-(3,5-二甲氧基苯基)吡啶并[2,3-D-7-嘧啶基]-N'-(1,1-二甲基)脲 | 1-tert-butyl-3-[2-{[4-(diethylamino)butyl]amino}-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]urea | C28H41N7O3 | |
| 27 | 22978-25-2 | 2-氯-5-硝基-N-苯基苯酰胺 | 2-chloro-5-nitro-N-phenylbenzamide | C13H9ClN2O3 | |
| 28 | 257933-82-7 | 培利替尼 | Pelitinib | C24H23ClFN5O2 | |
| 29 | 26095-59-0 | 奥替溴铵 | Otilonium bromide | C29H43BrN2O4 | |
| 30 | 269055-15-4 | 依曲韦林 | Etravirine | C20H15BrN6O | |
| 31 | 345627-80-7 | N-[5-[(5-叔丁基-1,3-恶唑-2-基)甲硫基]-1,3-噻唑-2-基]哌啶-4-甲酰胺 | N-[5-[(5-tert-Butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide | C17H24N4O2S2 | |
| 32 | 391210-10-9 | N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺 | N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide | C16H14F3IN2O4 | |
| 33 | 417716-92-8 | 乐伐替尼 | Lenvatinib | C21H16N6O2S2 | |
| 34 | 425386-60-3 | 司马西特 | Semagacestat | C19H27N3O4 | |
| 35 | 459868-92-9 | AG-014699 | 8-Fluoro-2-[4-(methylaminomethyl)phenyl]-3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indol-6-one phosphate | C19H21FN3O5P | |
| 36 | 477575-56-7 | PHA665752 | (3Z)-5-[(2,6-dichlorobenzyl)sulfonyl]-3-[(3,5-dimethyl-4-{[(2R)-2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]carbonyl}-1H-pyrrol-2-yl)methylidene]-1,3-dihydro-2H-indol-2-one | C32H34Cl2N4O4S | |
| 37 | 519055-62-0 | 他斯索兰 | Tasisulam | C11H6BrCl2NO3S2 | |
| 38 | 552325-73-2 | (alphaS)-alpha-[[[5-(3-甲基-1H-吲唑-5-基)-3-吡啶基]氧]甲基]苯乙胺 | (2S)-1-{[5-(3-Methyl-2H-indazol-5-yl)-3-pyridinyl]oxy}-3-phenyl-2-propanamine | C22H22N4O | |
| 39 | 555-55-5 | 牛奶树碱 | Hispidine | C13H10O5 | |
| 40 | 566-48-3 | 福美斯坦 | 4-androsten-4-ol-3,17-dione | C20H28O2 | |
| 41 | 586966-54-3 | 匹伐他汀叔丁酯 | Pitavastatin tert-Butyl Ester | C29H32FNO4 | |
| 42 | 658084-23-2 | SU 11274 | (3Z)-N-(3-chlorophenyl)-3-({3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl}methylidene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide | C28H30ClN5O4S | |
| 43 | 670220-88-9 | [1-[2-[5-(3-甲基氧杂环丁烷-3-基甲氧基)苯并咪唑-1-基]喹啉-8-基]哌啶-4-基]胺 | Crenolanib | C26H29N5O2 | |
| 44 | 702674-56-4 | BX-912 | BX-912 | C20H23BrN8O | |
| 45 | 763113-22-0 | 1-(环丙甲酰基)-4-[5-[(3,4-二氢-4-氧代-1-酞嗪基)甲基]-2-氟苯甲酰]哌嗪 | Olaparib | C24H23FN4O3 | |
| 46 | 78712-43-3 | 盐酸奥扎格雷 | Ozagrel hydrochloride | C13H13ClN2O2 | |
| 47 | 863031-21-4 | 1-[[2'-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)[1,1'-联苯]-4-基]甲基]-2-乙氧基-1H-苯并咪唑-7-羧酸 (5-甲基-2-氧代-1,3-二恶茂-4-基)甲酯 | Azilsartan medoxomil | C30H24N4O8 | |
| 48 | 868540-17-4 | 卡非佐米 | Carfilzomib | C40H57N5O7 | |
| 49 | 871224-64-5 | 阿莫伦特 | (2R)-[6,7-Dimethoxy-1(S)-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,2,3,4-tetrahydroisoquinolin-2-yl]-N-methyl-2-phenylacetamide | C29H31F3N2O3 | |
| 50 | 873697-71-3 | 4-[[2-氟-3-[N'-(6-甲基吡啶-3-基)脲基]苯基]甲基]哌嗪-1-羧酸甲酯 | 1-Piperazinecarboxylic acid,4-[[2-fluoro-3-[[[(6-methyl-3-pyridinyl)amino]carbonyl]amino]phenyl]methyl]-, methyl ester | C20H24FN5O3 | |
| 51 | 89778-27-8 | 枸橼酸托瑞米芬 | TOREMIFENE CITRATE | C32H36ClNO8 | |
| 52 | 939791-38-5 | PF-562271苯磺酸盐 | PF-562271 benzenesulfonate salt | C27H26F3N7O6S2 | |
| 53 | 943540-75-8 | 6-[二氟[6-(1-甲基-1H-吡唑-4-基)-1,2,4-噻唑并[4,3-b]吡嗪-3-基]甲基]-喹啉 | 6-[difluoro-[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[3,4-f]pyridazin-3-yl]methyl]quinoline | C19H13F2N7 | |
| 54 | 944396-07-0 | 5-[2,6-二(4-吗啉基)-4-嘧啶基]-4-(三氟甲基)-2-吡啶胺 | 5-[2,6-Di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine | C18H21F3N6O2 | |
| 55 | 95734-82-0 | 奈达铂 | Nedaplatin | C2H6N2O3Pt | |
| 56 | 865759-25-7 | 曲格列汀 | Trelagliptin | C18H20FN5O2 | |
| 57 | 507475-17-4 | TPCA-1 | TPCA-1 | C12H10FN3O2S | |
| 58 | 677297-51-7 | TG100-115 | TG100-115 | C18H14N6O2 | |
| 59 | 869363-13-3 | MLN8054 | MLN8054 | C25H15ClF2N4O2 | |
| 60 | 867160-71-2 | Linsitinib | Linsitinib | C26H23N5O | |
| 61 | 950769-58-1 | N-(5-tert-Butylisoxazol-3-yl)-N-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea | N-(5-tert-Butylisoxazol-3-yl)-N-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea | C29H32N6O4S | |
| 62 | 154447-36-6 | 2-(4-MORPHOLINO)-8-PHENYL-4H-1-BENZOPYRAN-4-ON | 2-(4-MORPHOLINO)-8-PHENYL-4H-1-BENZOPYRAN-4-ON | C19H17NO3 | |
| 63 | 606143-89-9 | Binimetinib | Binimetinib | C17H15BrF2N4O3 | |
| 64 | 936623-90-4 | 沙库必曲|缬沙坦 | Sacubitril|Valsartan | C48H58N6O8 | |
| 65 | 59338-87-3 | 盐酸阿立必利 | Alizapride hydrochloride | C16H22ClN5O2 | |
| 66 | 317318-84-6 | GW0742 | GW0742 | C21H17F4NO3S2 | |
| 67 | 1229194-11-9 | 依度沙班对甲苯磺酸盐一水化合物 | Edoxaban (tosylate Monohydrate) | C31H38ClN7O7S2 | |
| 68 | 1228690-36-5 | [4'-[3-甲基-4-[[[((R)-1-苯基乙基)氧基]羰基]氨基]异恶唑-5-基]联苯-4-基]乙酸 | AM095 | C27H24N2O5 | |
| 69 | 19542-67-7 | (E)-3-甲苯磺酰基丙烯腈 | BAY 11-7082 | C10H9NO2S | |
| 70 | 177834-92-3 | 依来曲普坦氢溴酸盐 | Eletriptan hydrobromide | C22H26N2O2S | |
| 71 | 14176-50-2 | 盐酸替来他明 | TILETAMINE HYDROCHLORIDE | C12H18ClNOS | 盐酸替来他明是一种白色粉末状物质，主要用于封闭麻醉及全身麻醉。 |
| 72 | 66104-23-2 | 甲磺酸培高利特 | Pergolide mesylate salt | C20H30N2O3S2 | |
| 73 | 61350-00-3 | N-(3-氯苯基)-2-吡啶甲酰胺 | 2-PyridinecarboxaMide, N-(3-chlorophenyl)- | C12H9ClN2O | |
| 74 | 1369764-02-2 | 莱博雷生 | Lemborexant | C22H20F2N4O2 | |
| 75 | 3258-02-4 | N-羟基胞苷 | N(4)-hydroxycytidine | C9H13N3O6 | |
| 76 | 155148-31-5 | 盐酸普乐沙福 | Plerixafor hcl | C28H54N8 | |
| 77 | 1642288-47-8 | 玛伐凯泰 | MYK-461 | C15H19N3O2 | |
| 78 | 1454846-35-5 | 劳拉替尼 | Lorlatinib | C21H19FN6O2 | |
| 79 | 857890-39-2 | 乐伐替尼甲磺酸盐 | Lenvatinib mesylate | C22H23ClN4O7S | |
| 80 | 1029712-80-8 | 卡马替尼 | Capmatinib | C23H17FN6O | |
| 81 | 1257044-40-8 | 维萘妥拉 | ABT-199 | C45H50ClN7O7S | |
| 82 | 1197958-12-5 | AP26113 | Brigatinib-analog | C26H34ClN6O2P | |
| 83 | 1092364-38-9 | 泊齐替尼 | Poziotinib | C23H21Cl2FN4O3 | |
| 84 | 1421373-65-0 | 奥西替尼 | AZD9291 | C28H33N7O2 | |
| 85 | 1256580-46-7 | 艾乐替尼 | Alectinib | C30H34N4O2 | |
| 86 | 1402836-58-1 | 1-环己基-2-(5H-咪唑并[5,1-A]异吲哚-5-基)乙醇 | NLG919 | C18H22N2O | |
| 87 | 1346574-57-9 | GSK 126 | 1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-(6-piperazin-1-ylpyridin-3-yl)indole-4-carboxamide | C31H38N6O2 | |
| 88 | 700874-72-2 | LY 2157299 | LY 2157299 | C22H19N5O | |
| 89 | 1009298-09-2 | AZD8055 | AZD-8055 | C25H31N5O4 | |
| 90 | 85650-56-2 | 阿塞那平马来酸盐 | Asenapine Maleate | C21H20ClNO5 | |
| 91 | 953769-46-5 | BLZ945 | 4-((2-(((1R,2R)-2-hydroxycyclohexyl)aMino)benzo[d]thiazol-6-yl)oxy)-N-MethylpicolinaMide | C20H22N4O3S | |
| 92 | 1228591-30-7 | N-[7-氰基-6-[4-氟-3-[[[3-(三氟甲基)苯基]乙酰基]氨基]苯氧基]-1,3-苯并噻唑-2-基]环丙烷甲酰胺 | N-[7-cyano-6-[4-fluoro-3-[[2-[3-(trifluoromethyl)phenyl]acetyl]amino]phenoxy]-1,3-benzothiazol-2-yl]cyclopropanecarboxamide | C27H18F4N4O3S | |
| 93 | 697761-98-1 | 埃替拉韦 | elvitegravir | C23H23ClFNO5 | |
| 94 | 872511-34-7 | FGFR抑制剂(NVP-BGJ398) | NVP-BGJ398 | C26H31Cl2N7O3 | |
| 95 | 1229705-06-9 | 依达奴林 | RG 7388 | C31H29Cl2F2N3O4 | |
| 96 | 6101-15-1 | 司可林 | Succinylcholine chloride dihydrate | C14H34Cl2N2O6 | |
| 97 | 109581-93-3 | 他克莫司一水合物 | TACROLIMUS | C44H69NO12.H2O | |
| 98 | 284028-89-3 | 3,5,7,8-四氢-2-[4-(三氟甲基)苯基]-4H-噻喃并[4,3-D]嘧啶-4-酮 | xav-939 | C14H11F3N2OS | |
| 99 | 1032568-63-0 | 库潘尼西 | BAY 80-6946 (Copanlisib) | C23H28N8O4 | |
| 100 | 414864-00-9 | 贝利司他(PXD101) | Belinostat (PXD101) | C15H14N2O4S | 一种新型HDAC抑制剂 |
| 101 | 1035270-39-3 | AZD-4547 | AZD-4547 | C26H33N5O3 | |
| 102 | 1037624-75-1 | 1-(6,7-二氢-5H-苯并[6,7]环庚烷并[1,2-C]哒嗪-3-基)-N3-[(7S)-6,7,8,9-四氢-7-(1-吡咯烷基)-5H-苯并环庚烯-2-基]-1H-1,2,4-三唑-3,5- | 1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-[(7S)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5H-benzocyclohepten-2-yl]-1H-1,2,4-triazole-3,5-diamine | C30H34N8 | |
| 103 | 193611-67-5 | 化合物 T23315 | N-[3-[3-(Dimethylamino)ethoxy]-4-methoxyphenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-carboxamide hydrochloride PFI-3 | C28H31ClN4O4 | |
| 104 | 1420290-99-8 | 2-(2-氨基乙氧基)-5-氯-N-(2-氯-4-硝基苯基)苯甲酰胺盐酸盐 | 2-(2-Aminoethoxy)-5-chloro-N-(2-chloro-4-nitrophenyl)benzamide hydrochloride | C15H14Cl3N3O4 | |
| 105 | 1338540-63-8 | (R)-9-(4-(1-氨基丙-2-基)苯基)-8-羟基-6-甲基噻吩并[2,3-C]喹啉-4(5H)-酮 | 9-[4-[(1R)-2-Amino-1-methylethyl]phenyl]-8-hydroxy-6-methylthieno[2,3-c]quinolin-4(5H)-one | C21H20N2O2S | 用途 OTS514是一种有效的t淋巴因子激活杀伤细胞源性蛋白激酶(TOPK)抑制剂。TOPK参与了癌症细胞增殖和癌症干细胞维护。OTS514还向下调节致癌转录因子叉头盒蛋白M1（FOXM1）。 |
| 106 | 1691249-45-2 | 泽布替尼 | Zanubrutinib | C27H29N5O3 | |
| 107 | 1818314-88-3 | BMS-1166 | PD-1|PD-L1-IN1 | C36H33ClN2O7 | |
| 108 | 2621928-55-8 | 4-[4-(3,8-二氮杂双环[3.2.1]OCT-3-基)-8-氟-2-[(2R,7AS)-2-氟四氢-1H-吡咯里嗪-7A(5H)-基]甲氧基]吡啶基[4,3-D]嘧啶-7-基]-5-乙炔基-6-氟-2-萘醇 | 2-Naphthalenol, 4-[4-(3,8-diazabicyclo[3.2.1]oct-3-yl)-8-fluoro-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]pyrido[4,3-d]pyrimidin-7-yl]-5-ethynyl-6-fluoro- | C33H31F3N6O2 | |
| 109 | 2630904-45-7 | MRTX-1719 | MRTX-1719 | C23H18ClFN6O2 | |
| 110 | 1072833-77-2 | 艾沙佐米 | (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid | C14H19BCl2N2O4 | |
| 111 | 1044870-39-4 | 2-(4-(2-羟基乙氧基)-3,5-二甲基苯基)-5,7-二甲氧基喹唑啉-4(3H)-酮 | 2-(4-(2-Hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one | C20H22N2O5 | |
| 112 | 3690-10-6 | 2-嘧啶酮-B-核甙 | ZEBULARINE | C9H12N2O5 | |
| 113 | 6129-66-4 | 4-羟基苯基-Β-D-吡喃葡萄糖苷-2,3,4,6-四乙酸酯 | 4-hydroxyphenyl-β-D-Glucopyranoside-2,3,4,6-tetraacetate | C20H24O11 | |
| 114 | 3690-10-6 | 2-嘧啶酮-B-核甙 | 4-Deoyuridine | C9H12N2O5 | |
| 115 | 1700637-55-3 | CD38 inhibitor | CD38 inhibitor 78c | C22H27N3O3S | |
| 116 | 16611-84-0 | 银杏酸C15:0 | Ginkgolic acid C15:0 | C22H36O3 | |
| 117 | 184025-18-1 | Ciproxifan | Ciproxifan | C16H18N2O2 | |
| 118 | 714272-27-2 | Plinabulin (NPI-2358) | Plinabulin (NPI-2358) | C19H20N4O2 | |
| 119 | 1357576-48-7 | AZD4320 | AZD4320 | C45H48ClF3N4O7S3 | |
| 120 | 2089288-03-7 | AZD-1390 | AZD-1390 | C27H32FN5O2 | |
| 121 | 1034895-42-5 | 9-ING-41 | 9-ING-41 | C22H13FN2O5 | |
| 122 | 2169916-18-9 | VTP50469 | VTP50469 | C32H47FN6O4S | |
| 123 | 21102-95-4 | 8-(2-(4-(2-Methoxyphenyl)piperazin-1-yl)ethyl)-8-azaspiro[4.5]decane-7,9-dione dihydrochloride | 8-(2-(4-(2-Methoxyphenyl)piperazin-1-yl)ethyl)-8-azaspiro[4.5]decane-7,9-dione dihydrochloride | C22H32ClN3O3 | |
| 124 | 487021-52-3 | AR-A014418 | AR-A014418 | C12H12N4O4S | |
| 125 | 126643-37-6 | 蛋白激酶仰制剂KT5823 | KT5823 | C29H25N3O5 | |
| 126 | 209481-20-9 | SB271046 | SB271046 | C20H22ClN3O3S2 | |
| 127 | 1396841-57-8 | RGFP966 | RGFP966 | C21H19FN4O | |
| 128 | 1448867-41-1 | NVP-HDM201 | NVP-HDM201 | C26H24Cl2N6O4 | |
| 129 | 1050500-29-2 | N-[4-[[3-氯-4-[(3-氟苯基)甲氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯酰胺对甲苯磺酸盐 | AST-1306 TsOH | C31H26ClFN4O5S | |
| 130 | 1173900-33-8 | 2-[[(1R)-1-[7-甲基-2-(4-吗啉基)-4-氧代-4H-吡啶并[1,2-a]嘧啶-9-基]乙基]氨基]苯甲酸 | AZD6482 | C22H24N4O4 | |
| 131 | 1191252-49-9 | IOWH032 | IOWH032 | C22H15Br2N3O4 | |
| 132 | 1191951-57-1 | PHT-427 | PHT-427 | C20H31N3O2S2 | |
| 133 | 1196109-52-0 | PF-3845 | PF-3845 | C24H23F3N4O2 | |
| 134 | 1202757-89-8 | N-[3-[[5-氟-2-[[4-(2-甲氧基乙氧基)苯基]氨基]-4-嘧啶基]氨基]苯基]-2-丙烯酰胺 | AVL-292 | C22H22FN5O3 | |
| 135 | 1219168-18-9 | Dorsomorphin 2HCl | Dorsomorphin 2HCl | C24H27Cl2N5O | |
| 136 | 1222781-70-5 | (4-甲氧基苄基)(1-萘基甲基)胺盐酸盐 | ML133 HCl | C19H20ClNO | |
| 137 | 1223001-51-1 | Torin 2 | Torin 2 | C24H15F3N4O | |
| 138 | 1254473-64-7 | 4-[(1E)-2-[5-[(1R)-1-(3,5-二氯-4-吡啶基)乙氧基]-1H-吲唑-3-基]乙烯基]-1H-吡唑-1-乙醇 | LY2874455 | C21H19Cl2N5O2 | |
| 139 | 1258861-20-9 | 4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺 | LY2940680 | C26H24F4N6O | |
| 140 | 1262036-50-9 | N-[3-[(4aS,7aS)-2-氨基-4a,5-二氢-4H-呋喃并[3,4-d][1,3]噻嗪-7a(7H)-基]-4-氟苯基]-5-氟-2-吡啶甲酰胺 | LY2886721 | C18H16F2N4O2S | |
| 141 | 130964-39-5 | H 89 2HCl | H 89 2HCl | C20H20BrN3O2S.2ClH.H2O | |
| 142 | 1333151-73-7 | KPT-185 | KPT-185 | C16H16F3N3O3 | |
| 143 | 154447-35-5 | 2-(4-吗啉基)-4H-萘并[1,2-B]吡喃-4-酮 | NU7026 | C17H15NO3 | |
| 144 | 156897-06-2 | Licofelone | Licofelone | C23H22ClNO2 | |
| 145 | 157716-52-4 | Perifosine (KRX-0401) | Perifosine (KRX-0401) | C25H52NO4P | |
| 146 | 196868-63-0 | N-(5-氯-2-甲氧基苯基)-N'-(2-甲基-4-喹啉基)脲 | PQ 401 | C18H16ClN3O2 | |
| 147 | 208260-29-1 | ZM 336372 | ZM 336372 | C23H23N3O3 | |
| 148 | 211555-04-3 | WHI-P154 | WHI-P154 | C16H14BrN3O3 | |
| 149 | 213261-59-7 | RITA (NSC 652287) | RITA (NSC 652287) | C14H12O3S2 | |
| 150 | 261901-57-9 | SB269970 HCl | SB269970 HCl | C18H28N2O3SHCl | |
| 151 | 2854-32-2 | BML-190 | BML-190 | C23H23ClN2O4 | |
| 152 | 289905-88-0 | TRAM-34 | TRAM-34 | C22H17ClN2 | |
| 153 | 304448-55-3 | 3-羟基-2-萘甲酸[(3,4-二羟基苯基)亚甲基]酰肼 | Dynasore | C18H14N2O4 | |
| 154 | 380315-80-0 | Tenovin-1 | Tenovin-1 | C20H23N3O2S | |
| 155 | 403811-55-2 | 5-(4-乙基苯亚甲基)绕丹宁 | (Z,E)-5-(4-ETHYLBENZYLIDINE)-2-THIOXOTHIAZOLIDIN-4-ONE | C12H11NOS2 | |
| 156 | 438190-29-5 | SMI-4a | SMI-4a | C11H6F3NO2S | |
| 157 | 501925-31-1 | PNU-120596 | N-(5-CHLORO-2,4-DIMETHOXYPHENYL)-N'-(5-METHYL-3-ISOXAZOLYL)-UREA | C13H14ClN3O4 | |
| 158 | 537705-08-1 | CP-724714 | CP-724714 | C27H27N5O3 | |
| 159 | 57477-39-1 | BRL-54443 | BRL-54443 | C14H18N2O | |
| 160 | 648449-76-7 | 5-[(2,2-二氟-1,3-苯并二恶茂-5-基)亚甲基]噻唑烷-2,4-二酮 | AS-604850 | C11H5F2NO4S | |
| 161 | 702675-74-9 | BX-795 盐酸盐 | BX-795 盐酸盐 | C23H26IN7O2S | |
| 162 | 717906-29-1 | PF-431396 | PF-431396 | C22H21F3N6O3S | |
| 163 | 726169-73-9 | Mocetinostat (MGCD0103) | Mocetinostat (MGCD0103) | C23H20N6O | |
| 164 | 780757-88-2 | (6R,9AR)-REL-六氢-6-[(4-羟基苯基)甲基]-8-(1-萘基甲基)-4,7-二氧代-N-(苯基甲基)-2H-吡嗪并[1,2-A]嘧啶-1(6H)-甲酰胺 | (6S,9aS)-6-(4-Hydroxybenzyl)-8-[(naphthalen-1-yl)methyl]-4,7-dioxohexahydropyrazino[1,2-a]pyrimidine-1-carboxylic acid N-benzylamide | C33H32N4O4 | |
| 165 | 79183-19-0 | Apoptosis Activator 2 | Apoptosis Activator 2 | C15H9Cl2NO2 | |
| 166 | 905973-89-9 | CGK 733 | CGK 733 | C23H18Cl3FN4O3S | |
| 167 | 1619994-69-2 | Bromosporine | Bromosporine | C17H20N6O4S | |
| 168 | 908112-43-6 | SNX-2112 (PF-04928473) | SNX-2112 (PF-04928473) | C23H27F3N4O3 | |
| 169 | 1001264-89-6 | GDC-0068 | GDC-0068 | C24H32ClN5O2 | |
| 170 | 1001350-96-4 | BMS-754807 | BMS-754807 | C23H24FN9O | |
| 171 | 1002304-34-8 | AMG-208 | 7-methoxy-4-((6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy)quinoline | C22H17N5O2 | |
| 172 | 1009817-63-3 | b-AP15 ( NSC 687852) | (3E,5E)-1-Acryloyl-3,5-bis(4-nitrobenzylidene)piperidin-4-one | C22H17N3O6 | |
| 173 | 1010085-13-8 | MK-5108 (VX-689) | MK-5108 (VX-689) | C22H21ClFN3O3S | |
| 174 | 1012054-59-9 | CUDC-101 | CUDC-101 | C24H26N4O4 | |
| 175 | 1020172-07-9 | DCC-2036 (Rebastinib) | DCC-2036 (Rebastinib) | C30H28FN7O3 | |
| 176 | 1025065-69-3 | SGI-1776 free base | SGI-1776 free base | C20H22F3N5O | |
| 177 | 1026785-59-0 | VX-222 (VCH-222, Lomibuvir) | VX-222 (VCH-222, Lomibuvir) | C25H35NO4S | |
| 178 | 1030612-90-8 | MK-8245 | MK-8245 | C17H16BrFN6O4 | |
| 179 | 1037184-44-3 | YK-4-279 | YK-4-279 | C17H13Cl2NO4 | |
| 180 | 1048371-03-4 | UPF 1069 | UPF 1069 | C17H13NO3 | |
| 181 | 1051375-10-0 | Cabotegravir | Cabotegravir | C19H17F2N3O5 | |
| 182 | 1056901-62-2 | AT13148 | AT13148 | C17H16ClN3O | |
| 183 | 1059734-66-5 | BMS-833923 | BMS-833923 | C30H27N5O | |
| 184 | 1061353-68-1 | PND-1186 | PND-1186 | C25H26F3N5O3 | |
| 185 | 1062169-56-5 | WYE-354 | WYE-354 | C24H29N7O5 | |
| 186 | 1062368-24-4 | LDN-193189 | LDN-193189 | C25H22N6 | |
| 187 | 1062368-49-3 | LDN 193719 | LDN 193719 | C22H16N4O | |
| 188 | 1082949-68-5 | LY-2584702 (tosylate salt) | LY-2584702 (tosylate salt) | C28H27F4N7O3S | |
| 189 | 108409-83-2 | FH535 | FH535 | C13H10Cl2N2O4S | |
| 190 | 1092499-93-8 | NVP-BSK805 | NVP-BSK805 | C27H28F2N6O | |
| 191 | 1093403-33-8 | SRT 2104 | SRT 2104 | C26H24N6O2S2 | |
| 192 | 1095382-05-0 | CCT137690 | CCT137690 | C26H31BrN8O | |
| 193 | 1097917-15-1 | ASP3026 | ASP3026 | C29H40N8O3S | |
| 194 | 1100598-32-0 | EMD 1214063 | EMD 1214063 | C29H28N6O2 | |
| 195 | 1124329-14-1 | AZ 3146 | 9-cyclopentyl-2-(2-methoxy-4-(1-methylpiperidin-4-yloxy)phenylamino)-7-methyl-7H-purin-8(9H)-one | C24H32N6O3 | |
| 196 | 1127442-82-3 | IWR-1-endo | IWR-1-endo | C25H19N3O3 | |
| 197 | 1129669-05-1 | IM-12 | IM-12 | C22H20FN3O2 | |
| 198 | 1138549-36-6 | CX-5461 | CX-5461 | C27H27N7O2S | |
| 199 | 1144068-46-1 | WYE-125132 (WYE-132) | WYE-125132 (WYE-132) | C27H33N7O4 | |
| 200 | 1158838-45-9 | Aurora A Inhibitor I | Aurora A Inhibitor I | C31H31ClFN7O2 | |
| 201 | 1161205-04-4 | VU 0361737 | VU 0361737 | C13H11ClN2O2 | |
| 202 | 1174043-16-3 | AZD2461 | 2-Pyrazinecarboxamide, 3-amino-6-[4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-N-3-pyridinyl- | C22H22FN3O3 | |
| 203 | 1174046-72-0 | BMS-794833 | BMS-794833 | C23H15ClF2N4O3 | |
| 204 | 1177865-17-6 | NSC 23766 | NSC 23766 | C24H35N7 | |
| 205 | 1185763-69-2 | NVP-BVU972 | NVP-BVU972 | C20H16N6 | |
| 206 | 1186486-62-3 | Evacetrapib (LY2484595) | Evacetrapib (LY2484595) | C31H36F6N6O2 | |
| 207 | 1206101-20-3 | GLPG0634 analog | N-[5-[4-[(6-Cyano-3-pyridinyl)methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl] cyclopropanecarboxa | C23H18N6O2 | |
| 208 | 1206711-16-1 | DMH 1 | DMH 1 | C24H20N4O | |
| 209 | 1211441-98-3 | 瑞博西尼杂质 | LEE011 | C23H30N8O | |
| 210 | 1218777-13-9 | CAY10505 | CAY10505 | C14H8FNO3S | |
| 211 | 121917-57-5 | (-)-MK 801 Maleate | (-)-MK 801 Maleate | C20H19NO4 | |
| 212 | 1222998-36-8 | 1-[4-[4-(1-氧代丙基)-1-哌嗪基]-3-(三氟甲基)苯基]-9-(3-喹啉基)苯并[H]-1,6-萘啶-2(1H)-酮 | 1-[4-[4-(1-Oxopropyl)-1-piperazinyl]-3-(trifluoromethyl)phenyl]-9-(3-quinolinyl)benzo[h]-1,6-naphthyridin-2(1H)-one | C35H28F3N5O2 | |
| 213 | 1227911-45-6 | GSK2334470游离态 | GSK2334470 | C25H34N8O | |
| 214 | 1231930-82-7 | N-[5-[(4-乙基-1-哌嗪基)甲基]-2-吡啶基]-5-氟-4-[4-氟-2-甲基-1-异丙基-1H-苯并咪唑-6-基]-2-嘧啶胺甲烷磺酸盐 | 2-Pyrimidinamine, N-[5-[(4-ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimida | C27H32F2N8.CH4O3S | |
| 215 | 1240299-33-5 | AZD3514 | AZD3514 | C25H32F3N7O2 | |
| 216 | 1243244-14-5 | LGK974 | LGK974 | C23H20N6O | |
| 217 | 124431-80-7 | CGS 21680 HCL | CGS 21680 HCL | C23H30ClN7O6 | |
| 218 | 1245537-68-1 | BGT226 (NVP-BGT226) | 8-(6-methoxypyridin-3-yl)-3-methyl-1-(4-(piperazin-1-yl)-3-(trifluoromethyl)phenyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one Maleic a | C28H25F3N6O2.C4H4O4 | |
| 219 | 1246560-33-7 | VS-5584 (SB2343) | VS-5584 (SB2343) | C17H22N8O | |
| 220 | 1247819-59-5 | P22077 | P22077 | C12H7F2NO3S2 | |
| 221 | 1251156-08-7 | XL388 | XL388 | C23H22FN3O4S | |
| 222 | 1252003-15-8 | Tubastatin-A | Tubastatin-A | C20H21N3O2 | |
| 223 | 1255517-76-0 | PF-4708671 | PF-4708671 | C19H21F3N6 | |
| 224 | 1260251-31-7 | Birinapant | Birinapant | C42H56F2N8O6 | |
| 225 | 1260907-17-2 | GSK 525762A | GSK 525762A | C22H22ClN5O2 | |
| 226 | 1286739-19-2 | FRAX597 | FRAX597 | C29H28ClN7OS | |
| 227 | 1300031-49-5 | I-BET151 | I-BET151 | C23H21N5O3 | |
| 228 | 1303607-60-4 | SAR405838 | SAR405838 | C29H34Cl2FN3O3 | |
| 229 | 1314890-29-3 | TMP269 | TMP269 | C25H21F3N4O3S | |
| 230 | 1316215-12-9 | Citarinostat | Citarinostat | C24H26ClN5O3 | |
| 231 | 1345675-02-6 | ETP-46464 | ETP-46464 | C30H22N4O2 | |
| 232 | 1355326-35-0 | AGI-5198 | AGI-5198 | C27H31FN4O2 | |
| 233 | 1364488-67-4 | YH239-EE | YH239-EE | C25H27Cl2N3O4 | |
| 234 | 1373423-53-0 | GSK-J4 | GSK-J4 | C24H27N5O2 | |
| 235 | 1373615-35-0 | PF-5274857 | PF-5274857 | C20H25ClN4O3S | |
| 236 | 1375465-09-0 | CNX-2006 | N-[3-[[2-[[4-[[1-(2-Fluoroethyl)-3-azetidinyl]amino]-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-py | C26H27F4N7O2 | |
| 237 | 1380288-87-8 | EPZ-5676 | EPZ-5676 | C30H42N8O3 | |
| 238 | 138489-18-6 | Ro 31-8220 Mesylate | Ro 31-8220 Mesylate | C25H23N5O2S | |
| 239 | 1397219-81-6 | BS-181 (hydrochloride) | BS-181 (hydrochloride) | C22H33ClN6 | |
| 240 | 1401223-22-0 | PI-1840 | N-isopropyl-2-(4-propylphenoxy)-N-((3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide | C22H26N4O3 | |
| 241 | 1403783-31-2 | Nexturastat A | Nexturastat A | C19H23N3O3 | |
| 242 | 1410880-22-6 | JNK-IN-8 | JNK-IN-8 | C29H29N7O2 | |
| 243 | 1415800-43-9 | UNC 1215 | UNC 1215 | C32H43N5O2 | |
| 244 | 1418033-25-6 | LMK 235 | LMK 235 | C15H22N2O4 | LMK-235 is a selective histone deacetylase (HDAC) 4 and HDAC5 inhibitor. LMK-235 demonstrates activity against chemoresistant cancer cell lines in an MTT assay for cytotoxicity using human ovarian cancer cell lines A2780 and cisplatin resistant A2780CisR (IC50 = 0.49 and 0.32 μ M respectively). |
| 245 | 1421227-52-2 | WS3 | N-(6-(4-(3-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)ureido)phenoxy)pyrimidin-4-yl)cyclopropanecarboxamide | C28H30F3N7O3 | |
| 246 | 1421227-53-3 | WS6 | WS6 | C29H31F3N6O3 | |
| 247 | 1427782-89-5 | IWP L6 (Porcn Inhibitor III) | 2-((4-Oxo-3-phenyl-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(5-phenylpyridin-2-yl)aceta | C25H20N4O2S2 | |
| 248 | 1429651-50-2 | HPOB | HPOB | C17H18N2O4 | |
| 249 | 1431985-92-0 | K02288 | K02288 | C20H20N2O4 | |
| 250 | 1432597-26-6 | LDN-212854 | 5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline | C25H22N6 | |
| 251 | 1432660-47-3 | AGI-6780 | AGI-6780 | C21H18F3N3O3S2 | |
| 252 | 1433953-83-3 | SAR131675 | SAR131675 | C18H22N4O4 | |
| 253 | 143851-98-3 | Elacridar hydrochloride | Elacridar hydrochloride | C34H33N3O5.ClH | |
| 254 | 1456632-40-8 | SH-4-54 | SH-4-54 | C29H27F5N2O5S | |
| 255 | 1457983-28-6 | G-749 | G-749 | C25H25BrN6O2 | |
| 256 | 1493694-70-4 | UNC2250 | (1r,4r)-4-((2-(Butylamino)-5-(5-(morpholinomethyl)pyridin-2-yl)pyrimidin-4-yl)amino)cyclohexanol | C24H36N6O2 | |
| 257 | 1493764-08-1 | UNC2881 | UNC2881 | C25H33N7O2 | |
| 258 | 153436-53-4 | AG-1478 (Tyrphostin AG-1478) | 4-(3-Chloroanilino)-6,7-Dimethoxyquinazoline Hydrochloride | C16H14ClN3O2 | |
| 259 | 154039-60-8 | Marimastat | Marimastat | C15H29N3O5 | |
| 260 | 1561178-17-3 | SGC-0946 | SGC-0946 | C28H40BrN7O4 | |
| 261 | 1572414-83-5 | ML-323 | ML-323 | C23H24N6 | |
| 262 | 1594094-64-0 | CW 069 | CW 069 | C23H21IN2O3 | |
| 263 | 172889-26-8 | PP1 | PP1 | C16H19N5 | |
| 264 | 179461-52-0 | PD 151746 | PD 151746 | C11H8FNO2S | |
| 265 | 180977-34-8 | FTI-277 (hydrochloride) | FTI-277 (hydrochloride) | C22H30ClN3O3S2 | |
| 266 | 182498-32-4 | SB225002 | SB 225002 | C13H10BrN3O4 | |
| 267 | 183322-45-4 | PD153035 HCl | PD153035 HCl | C16H14BrN3O2.HCl | |
| 268 | 188011-69-0 | N-(5-Bromopyridin-2-yl)succinamic acid | 4-[(5-bromopyridin-2-yl)amino]-4-oxobutanoic acid | C9H9BrN2O3 | |
| 269 | 192927-92-7 | LY310762 | LY310762 | C24H27O2N2FHCl | |
| 270 | 194423-06-8 | CL-387785 | CL-387785 | C18H13BrN4O | |
| 271 | 196309-76-9 | BAY 11-7085 | BAY 11-7085 | C13H15NO2S | |
| 272 | 209410-46-8 | VX-745 | VX-745 | C19H9Cl2F2N3OS | |
| 273 | 209984-56-5 | YO-01027 | YO-01027 | C26H23F2N3O3 | |
| 274 | 209984-57-6 | LY-411575 | LY-411575 | C26H23F2N3O4 | |
| 275 | 219793-45-0 | BTB06584 | BTB06584 | C19H12ClNO6S | |
| 276 | 220904-83-6 | GW5074 | GW5074 | C15H8Br2INO2 | |
| 277 | 228559-41-9 | Ki8751 | Ki8751 | C24H18F3N3O4 | |
| 278 | 252916-29-3 | TSU-68 (SU6668, Orantinib) | TSU-68 (SU6668, Orantinib) | C18H18N2O3 | |
| 279 | 252935-94-7 | CHIR-98014 | CHIR-98014 | C20H17Cl2N9O2 | |
| 280 | 254964-60-8 | Tasquinimod | Tasquinimod | C20H17F3N2O4 | |
| 281 | 292605-14-2 | SB 3CT | SB 3CT | C15H14O3S2 | |
| 282 | 301305-73-7 | TCS 359 | TCS 359 | C18H20N2O4S | |
| 283 | 313516-66-4 | T0070907 | T0070907 | C12H8ClN3O3 | |
| 284 | 313553-47-8 | INH1 (IBT13131) | N-[4-(2,4-Dimethylphenyl)-2-thiazolyl]benzamide | C18H16N2OS | |
| 285 | 313967-18-9 | FLI-06 | FLI-06 | C25H30N2O5 | |
| 286 | 314245-33-5 | IU1 | IU1 | C18H21FN2O | |
| 287 | 315183-21-2 | PAC-1 | PAC-1 | C23H28N4O2 | |
| 288 | 321674-73-1 | BIBR 1532 | BIBR 1532 | C21H17NO3 | |
| 289 | 327036-89-5 | TDZD-8 | TDZD-8 | C10H10N2O2S | |
| 290 | 328968-36-1 | C646 | C646 | C24H19N3O6 | |
| 291 | 331244-89-4 | BAM7 | BAX Activator Molecule 7 | C21H19N5O2S | |
| 292 | 331771-20-1 | ZM 447439 | ZM 447439 | C29H31N5O4 | |
| 293 | 355025-24-0 | Ki16425 | Ki16425 | C23H23ClN2O5S | |
| 294 | 356559-20-1 | SB525334 | SB525334 | C21H21N5 | |
| 295 | 371242-69-2 | IC-87114 | IC-87114 | C22H19N7O | |
| 296 | 371942-69-7 | YM201636 | YM201636 | C25H21N7O3 | |
| 297 | 372196-77-5 | PIK-75 | PIK-75 | C16H15BrClN5O4S | |
| 298 | 404951-53-7 | Dacinostat | 2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- | C22H25N3O3 | |
| 299 | 42521-82-4 | IPA-3 | IPA-3 | C20H14O2S2 | |
| 300 | 4311-88-0 | 5-(1H-吲哚-3-基甲基)-3-甲基-2-硫酮-4-咪唑烷酮 | Necrostatin-1 | C13H13N3OS | |
| 301 | 442632-72-6 | CK-636 | CK-636 | C16H16N2OS | |
| 302 | 443797-96-4 | JNJ-7706621 | JNJ-7706621 | C15H12F2N6O3S | |
| 303 | 4727-31-5 | 2-([1,1-联苯]-4-基氨基甲酰)苯甲酸 | Kartogenin | C20H15NO3 | |
| 304 | 475110-96-4 | ZSTK474 | ZSTK474 | C19H21F2N7O2 | |
| 305 | 475489-16-8 | NVP-AEW541 | NVP-AEW541 | C27H29N5O | |
| 306 | 486424-20-8 | AZD2858 | AZD2858 | C21H23N7O3S | |
| 307 | 500579-04-4 | GANT61 | GANT61 | C27H35N5 | |
| 308 | 501437-28-1 | BI-D1870 | BI-D1870 | C19H23F2N5O2 | |
| 309 | 518303-20-3 | UMI-77 | UMI-77 | C18H14BrNO5S2 | |
| 310 | 571203-78-6 | 2-[1-[4-[2-(4-氯苯氧基)乙酰基]-1-哌嗪基]乙基]-3-(2-乙氧基苯基)-4-(3H)-喹唑啉酮 | 2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone | C30H31ClN4O4 | |
| 311 | 582315-72-8 | BMS-265246 | BMS-265246 | C18H17F2N3O2 | |
| 312 | 587871-26-9 | KU-55933 (ATM Kinase Inhibitor) | KU-55933 (ATM Kinase Inhibitor) | C21H17NO3S2 | |
| 313 | 602306-29-6 | AZD5438 | 4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amine | C18H21N5O2S | |
| 314 | 603288-22-8 | LY2090314 | LY2090314 | C28H25FN6O3 | |
| 315 | 627536-09-8 | SD-208 | SD-208 | C17H10ClFN6 | |
| 316 | 648450-29-7 | AS-605240 | (Z)-5-(quinoxalin-6-ylmethylene)thiazolidine-2,4-dione | C12H7N3O2S | |
| 317 | 666260-75-9 | GW842166X | GW842166X | C18H17Cl2F3N4O2 | |
| 318 | 668467-91-2 | LDN 57444 | LDN 57444 | C17H11Cl3N2O3 | |
| 319 | 694433-59-5 | SB505124 | SB505124 | C20H21N3O2 | |
| 320 | 71441-28-6 | TTNPB | TTNPB | C24H28O2 | |
| 321 | 728033-96-3 | OSI-930 | OSI-930 | C22H16F3N3O2S | |
| 322 | 732302-99-7 | Givinostat (ITF2357) | Givinostat (ITF2357) | C24H30ClN3O5 | |
| 323 | 741713-40-6 | R547 | R547 | C18H21F2N5O4S | |
| 324 | 749886-87-1 | JSH-23 | 4-Methyl-N1-(3-phenylpropyl)benzene-1,2-diamine | C16H20N2 | |
| 325 | 755038-02-9 | BI 2536 | BI 2536 | C28H39N7O3 | |
| 326 | 778277-15-9 | GNF-5 | GNF-5 | C20H17F3N4O3 | |
| 327 | 799264-47-4 | ML130 (Nodinitib-1) | ML130 (Nodinitib-1) | C14H13N3O2S | |
| 328 | 801312-28-7 | GSK256066 | GSK256066 | C27H26N4O5S | |
| 329 | 847499-27-8 | CEP-18770 (Delanzomib) | CEP-18770 (Delanzomib) | C21H28BN3O5 | |
| 330 | 848695-25-0 | BIIB021 | BIIB021 | C14H15ClN6O | |
| 331 | 850173-95-4 | ADL5859 HCl | ADL5859 HCl | C24H29ClN2O3 | |
| 332 | 852808-04-9 | ABT-737 | ABT-737 | C42H45ClN6O5S2 | |
| 333 | 85416-73-5 | S- (+)-Rolipram | S- (+)-Rolipram | C16H21NO3 | |
| 334 | 856243-80-6 | Degrasyn (WP1130) | Degrasyn (WP1130) | C19H18BrN3O | |
| 335 | 860352-01-8 | AZD7762 | AZD7762 | C17H19FN4O2S | |
| 336 | 862507-23-1 | Ralimetinib dimesylate | Ralimetinib dimesylate | C26H37FN6O6S2 | |
| 337 | 864814-88-0 | Resminostat | Resminostat | C16H19N3O4S | |
| 338 | 865854-05-3 | Tideglusib | Tideglusib | C19H14N2O2S | |
| 339 | 868273-06-7 | Org 27569 | Org 27569 | C24H28ClN3O | |
| 340 | 869288-64-2 | PF-573228 | PF-573228 | C22H20F3N5O3S | |
| 341 | 871026-44-7 | TAK-285 | N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide | C26H25ClF3N5O3 | |
| 342 | 873225-46-8 | IKK-16 (IKK Inhibitor VII) | IKK-16 (IKK Inhibitor VII) | C28H29N5OS | |
| 343 | 873652-48-3 | GDC-0152 | GDC-0152 | C25H34N6O3S | |
| 344 | 875320-29-9 | Quisinostat (JNJ-26481585) | Quisinostat (JNJ-26481585) | C21H26N6O2 | Quisinostat (JNJ-26481585)是一种新型的，二代HDAC抑制剂，对HDAC作用最有效，IC50为0.11 nM，适度有效作用于HDACs 2， 4， 10，和11；比作用于HDACs 3， 5， 8，和9选择性强30倍，对HDACs 6和7作用效果最弱。 |
| 345 | 875337-44-3 | MGCD-265 | MGCD-265 | C26H20FN5O2S2 | |
| 346 | 877877-35-5 | TW-37 | TW-37 | C33H35NO6S | |
| 347 | 891494-63-6 | MK-8776 (SCH 900776) | MK-8776 (SCH 900776) | C15H18BrN7 | |
| 348 | 896705-16-1 | BMH-21 | BMH-21 | C21H20N4O2 | |
| 349 | 897016-82-9 | KX2-391 | KX2-391 | C26H29N3O3 | |
| 350 | 898044-15-0 | PF-3758309 | PF-3758309 | C25H30N8OS | |
| 351 | 923564-51-6 | Navitoclax | Navitoclax | C47H55ClF3N5O6S3 | |
| 352 | 927880-90-8 | RAF265 (CHIR-265) | RAF265 (CHIR-265) | C24H16F6N6O | |
| 353 | 929016-96-6 | Pracinostat (SB939) | Pracinostat (SB939) | C20H30N4O2 | |
| 354 | 931398-72-0 | IOX2 | IOX2 | C19H16N2O5 | |
| 355 | 934343-74-5 | HSP-990 | NVP-HSP990(HSP990) | C20H18FN5O2 | |
| 356 | 934353-76-1 | ENMD-2076 | ENMD-2076 | C21H25N7 | |
| 357 | 934660-93-2 | Cobimetinib | Cobimetinib | C21H21F3IN3O2 | |
| 358 | 936091-14-4 | TG101209 | TG101209 | C26H35N7O2S | |
| 359 | 936890-98-1 | OSI-027 | OSI-027 | C21H22N6O3 | |
| 360 | 937265-83-3 | ARRY-380 (analog ) | ARRY-380 (analog ) | C29H27N7O4S | |
| 361 | 937272-79-2 | Pacritinib | Pacritinib | C28H32N4O3 | |
| 362 | 938440-64-3 | KU-0063794 | KU-0063794 | C25H31N5O4 | |
| 363 | 940310-85-0 | NVP-BHG712 | NVP-BHG712 | C26H20F3N7O | |
| 364 | 940929-33-9 | SB743921 | SB743921 | C31H34Cl2N2O3 | |
| 365 | 942487-16-3 | PF-03814735 | PF-03814735 | C23H25F3N6O2 | |
| 366 | 944261-79-4 | A-803467 | 5-(4-chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide | C19H16ClNO4 | |
| 367 | 945755-56-6 | XL019 | XL019 | C25H28N6O2 | |
| 368 | 950455-15-9 | N-[(3-氯苯基)甲基]-螺[哌啶-4,2'(1'H)-喹喔啉]-3'-胺 | Liproxstatin-1 | C19H21ClN4 | |
| 369 | 950762-95-5 | PCI-34051 | PCI-34051 | C17H16N2O3 | |
| 370 | 955977-50-1 | PI-3065 | PI-3065 | C27H31FN6OS | |
| 371 | 957116-20-0 | MK-3207 (Hydrochloride) | MK-3207 (Hydrochloride) | C31H30ClF2N5O3 | |
| 372 | 99873-43-5 | Droxinostat | Droxinostat | C11H14ClNO3 | |
| 373 | 1052532-15-6 | SBE13 (Hydrochloride) | SBE13 (Hydrochloride) | C24H28Cl2N2O4 | |
| 374 | 1073485-20-7 | LDC000067 | LDC000067 | C18H18N4O3S | |
| 375 | 1078166-57-0 | PF-04418948 | PF-04418948 | C23H20FNO5 | |
| 376 | 1086062-66-9 | GSK2126458 (GSK458) | 2,4-difluoro-N-(2-methoxy-5-(4-(pyridazin-4-yl)quinolin-6-yl)pyridin-3-yl)benzenesulfonamide | C25H17F2N5O3S | |
| 377 | 1105698-15-4 | Salermide | Salermide | C26H22N2O2 | |
| 378 | 112648-68-7 | 1-[6-[((17Β)-3-雌酮-1,3,5[10]-三烯-17-基)氨基]乙基]-1H-吡咯-2,5-二酮 | 1-[6-[[(17B)-3-METHOXYESTRA-1,3,5(10)-TRIEN-17-YL]AMINO]HEXYL]-1H-PYRROLE-2,5-DIONE | C29H40N2O3 | |
| 379 | 1204144-28-4 | AZD1208 | AZD1208 | C21H21N3O2S | |
| 380 | 1214265-58-3 | WZ4003 | WZ4003 | C25H29ClN6O3 | |
| 381 | 1222800-79-4 | ML324 | ML324 | C21H23N3O2 | |
| 382 | 1227158-85-1 | BAY 87-2243 | BAY 87-2243 | C26H26F3N7O2 | |
| 383 | 1229208-44-9 | GS 9973 | GS 9973 | C23H21N7O | |
| 384 | 1234480-50-2 | XMD8-92 | 2-[[2-ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one | C26H30N6O3 | |
| 385 | 1234480-84-2 | LRRK2-IN-1 | LRRK2-IN-1 | C31H38N8O3 | |
| 386 | 1242156-23-5 | RN486 | RN486 | C35H35FN6O3 | |
| 387 | 1243243-89-1 | Wnt-C59 (C59) | Wnt-C59 (C59) | C25H21N3O | |
| 388 | 1271738-59-0 | MI-3 | MI-3 | C18H25N5S2 | |
| 389 | 1271738-62-5 | MI-2 | MI-2 | C18H25N5S2 | |
| 390 | 1276110-06-5 | HS-173 | HS-173 | C21H18N4O4S | |
| 391 | 1285515-21-0 | GSK2578215A | GSK2578215A | C24H18FN3O2 | |
| 392 | 1285702-20-6 | ML167 | ML167 | C19H17N3O3 | |
| 393 | 1300031-52-0 | GSK1324726A | GSK1324726A | C25H23ClN2O3 | |
| 394 | 1314241-44-5 | UNC 669 | (5-Bromopyridin-3-yl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone | C15H20BrN3O | |
| 395 | 1346704-33-3 | GSK343 | GSK343 | C31H39N7O2 | |
| 396 | 1374601-40-7 | BRD4770 | BRD4770 | C25H23N3O3 | |
| 397 | 1374828-69-9 | GNE-0877 | GNE-0877 | C14H16F3N7 | |
| 398 | 1380432-32-5 | EHop-016 | EHop-016 | C25H30N6O | |
| 399 | 1392136-43-4 | Verdinexor (KPT-335) | Verdinexor (KPT-335) | C18H12F6N6O | |
| 400 | 1393477-72-9 | 塞利尼索 | Selinexor (KPT-330) | C17H11F6N7O | |
| 401 | 1394076-92-6 | GNE-317 | GNE-317 | C19H22N6O3S | |
| 402 | 1395084-25-9 | MS436 | MS436 | C18H17N5O3S | |
| 403 | 1404456-53-6 | GSK 2830371 | GSK 2830371 | C23H29ClN4O2S | |
| 404 | 1417329-24-8 | MM-102 | MM-102 | C35H49F2N7O4 | |
| 405 | 1421919-75-6 | KPT-276 | KPT-276 | C16H10F8N4O | |
| 406 | 1431612-23-5 | UNC1999 | UNC1999 | C33H43N7O2 | |
| 407 | 1446144-04-2 | CPI-203 | CPI-203 | C19H18ClN5OS | |
| 408 | 1469337-95-8 | K-Ras(G12C) inhibitor 12 | K-Ras(G12C) inhibitor 12 | C15H17ClIN3O3 | |
| 409 | 1477949-42-0 | Santacruzamate A | Santacruzamate A | C15H22N2O3 | |
| 410 | 148741-30-4 | Tyrphostin AG 879 | Tyrphostin AG 879 | C18H24N2OS | |
| 411 | 1536200-31-3 | GNE-9605 | GNE-9605 | C17H20ClF4N7O | |
| 412 | 155270-99-8 | Istradefylline | Istradefylline | C20H24N4O4 | |
| 413 | 1616391-65-1 | EPZ015666 | EPZ015666 | C20H25N5O3 | |
| 414 | 1616632-77-9 | TIC10 | TIC10 | C24H26N4O | |
| 415 | 1622921-15-6 | Remodelin (hydrobromide) | Remodelin (hydrobromide) | C15H15BrN4S | |
| 416 | 173529-46-9 | HMN-214 | HMN-214 | C22H20N2O5S | |
| 417 | 178606-66-1 | U-104 | U-104 | C13H12FN3O3S | |
| 418 | 199596-05-9 | JIB-04 | JIB-04 | C17H13ClN4 | |
| 419 | 210344-95-9 | CASPASE-3抑制剂 | Z-DEVD-FMK | C30H41FN4O12 | |
| 420 | 244240-24-2 | LFM-A13 | LFM-A13 | C11H8Br2N2O2 | |
| 421 | 273404-37-8 | VX-765 | VX-765 | C24H33ClN4O6 | |
| 422 | 347174-05-4 | 3-氨基-4-环己基氨基苯甲酸乙酯 | Ferrostatin-1 (Fer-1) | C15H22N2O2 | |
| 423 | 348622-88-8 | UK 383367 | UK 383367 | C15H24N4O4 | |
| 424 | 422513-13-1 | Hesperadin | Hesperadin | C29H32N4O3S | |
| 425 | 50892-23-4 | WY-14643 | WY-14643 | C14H14ClN3O2S | |
| 426 | 537049-40-4 | Tubacin | Tubacin | C41H43N3O7S | |
| 427 | 586379-66-0 | PH-797804 | PH-797804 | C22H19BrF2N2O3 | |
| 428 | 587841-73-4 | ZCL278 | ZCL278 | C21H19BrClN5O4S2 | |
| 429 | 63208-82-2 | Pifithrin-α | Pifithrin-α | C16H19BrN2OS | |
| 430 | 71203-35-5 | ML141 | ML141 | C22H21N3O3S | |
| 431 | 837422-57-8 | WH-4-023 | WH-4-023 | C32H36N6O4 | |
| 432 | 857064-38-1 | WP1066 | WP1066 | C17H14BrN3O | |
| 433 | 865362-74-9 | FR 180204 | FR 180204 | C18H13N7 | |
| 434 | 872573-93-8 | Ro-3306 | Ro-3306 | C18H13N3OS2 | |
| 435 | 873436-91-0 | PU-H71 | PU-H71 | C18H21IN6O2S | |
| 436 | 882257-11-6 | Oxytocin-d5 | Oxytocin-d5 | C12H7Cl2NO3S2 | |
| 437 | 91396-88-2 | PluriSIn #1 (NSC 14613) | PluriSIn #1 (NSC 14613) | C12H11N3O | |
| 438 | 946518-60-1 | LY2409881 (trihydrochloride) | LY2409881 (trihydrochloride) | C24H30Cl2N6OS | |
| 439 | 1042224-63-4 | IRAK inhibitor 1 | IRAK inhibitor 1 | C17H19N5 | |
| 440 | 1186206-79-0 | ALW-II-41-27 | ALW-II-41-27 | C32H32F3N5O2S | |
| 441 | 1202402-40-1 | Triazolo-pyramidine derivative | Triazolo-pyramidine derivative | C20H21N7O3 | |
| 442 | 1334714-66-7 | 盐酸依拉环素 | Eravacycline dihydrochloride | C27H32ClFN4O8 | |
| 443 | 1360457-46-0 | Vaborbactam | Vaborbactam | C12H16BNO5S | |
| 444 | 129830-38-2 | 反式-4-[(R)-1-氨基乙基]-N-(4-吡啶基)环己烷甲酰胺二盐酸盐 | Y-27632 dihydrochloride | C14H23Cl2N3O | |
| 445 | 162520-00-5 | Salirasib | Salirasib | C22H30O2S | |
| 446 | 211555-05-4 | WHI-P97 | WHI-P97 | C16H13Br2N3O3 | |
| 447 | 262352-17-0 | Torcetrapib | Torcetrapib | C26H25F9N2O4 | |
| 448 | 431979-47-4 | SJ-172550 | SJ-172550 | C22H21ClN2O5 | |
| 449 | 511296-88-1 | Cyclic Pifithrin-α Hydrobromide | Cyclic Pifithrin-α Hydrobromide | C16H16N2S.HBr | |
| 450 | 55778-02-4 | WZ811 | WZ811 | C18H18N4 | |
| 451 | 761439-42-3 | TAE684 (NVP-TAE684) | TAE684 (NVP-TAE684) | C30H40ClN7O3S | |
| 452 | 778270-11-4 | GNF-2 | GNF-2 | C18H13F3N4O2 | |
| 453 | 848141-11-7 | Alvelestat | Alvelestat | C25H22F3N5O4S | |
| 454 | 960374-59-8 | ONX-0914 (PR-957) | (S)-3-(4-methoxyphenyl)-N-((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)propanamido)propanamide | C31H40N4O7 | |
| 455 | 72882-78-1 | CS-2703 | PF-9366 | C20H19ClN4 | |
| 456 | 1644342-14-2 | ML 792 | ML792 | C21H23BrN6O5S | |
| 457 | 1392399-03-9 | BIX 01294 | BIX 01294 Trihydrochloride | C28H41Cl3N6O2 | |
| 458 | 1445251-22-8 | ME0328 | ME0328 | C19H19N3O2 | |
| 459 | 1627676-59-8 | PFI-2 | PFI-2 | C23H25F4N3O3S | |
| 460 | 300801-52-9 | TG-003 | (1Z)-1-(3-Ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one | C13H15NO2S | |
| 461 | 676596-65-9 | 1-AZAKENPAULLONE | 1-AZAKENPAULLONE | C15H10BrN3O | |
| 462 | 76684-89-4 | E-64c | E-64c | C15H26N2O5 | |
| 463 | 849214-04-6 | CGAMP铵盐 | c-GpAp | C20H24N10O13P2 | |
| 464 | 909089-13-0 | SKL2001 | SKL-2001 | C14H14N4O3 | |
| 465 | 913822-46-5 | SC75741 | SC75741 | C29H23N7O2S2 | |
| 466 | 925701-49-1 | KU-60019 | KU-60019 | C30H33N3O5S | |
| 467 | 1338247-30-5 | BMS-3 | N-(5-(1-(2,6-dichlorophenyl)-3-(difluoroMethyl)-1H-pyrazol-5-yl)thiazol-2-yl)cyclopropanecarboxaMide | C17H12Cl2F2N4OS | |
| 468 | 1467057-23-3 | PF-06409577 | PF-06409577 | C19H16ClNO3 | |
| 469 | 1698055-85-4 | CPD1588 | ARS-1620 | C21H17ClF2N4O2 | |
| 470 | 1997387-43-5 | PZM-21 | 1-((S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl)-3-((S)-1-(thiophen-3-yl)propan-2-yl)urea | C19H27N3O2S | |
| 471 | 2141955-96-4 | BLU-782 | BLU-782 | C31H42N6O4 | |
| 472 | 2158197-70-5 | CS-2831 | HS1371 | C24H24N4O | |
| 473 | 2165322-94-9 | USP25 and 28 inhibitor AZ-1 | USP25/28 inhibitor AZ1； AZ1 | C17H16BrF4NO2 | |
| 474 | 314054-00-7 | C-176 | N-(4-iodophenyl)-5-nitrofuran-2-carboxamide | C11H7IN2O4 | |
| 475 | 1819363-80-8 | PFI-3 | PFI-3 | C19H19N3O2 | |
| 476 | 1262414-04-9 | Abediterol | Abediterol | C25H31N3O5 | |
| 477 | 1342278-01-6 | RKI-1447 | RKI-1447 | C16H14N4O2S | RKI-1447是一种有效的ROCK1和ROCK2抑制剂，IC50分别为14.5 nM和6.2 nM，有抗侵入和抗肿瘤活性。 |
| 478 | 2323027-38-7 | Ceapin-A7 | N-(1-(2,4-Bis(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-5-(furan-2-yl)isoxazole-3-carboxamide | C20H12F6N4O3 | |
| 479 | 831234-13-0 | AC1903 | 1-Benzyl-N-(2-furylmethyl)-1H-benzimidazol-2-amine | C19H17N3O | |
| 480 | 2314467-60-0 | OUN67600 | 4(3H)-Quinazolinone, 8-fluoro-3-[4-(4-fluorophenoxy)phenyl]-2-(4-methyl-1-piperazinyl)-, hydrochloride (1:1) | C25H23ClF2N4O2 | OUN67600, is a Novel Transient Receptor Potential Vanilloid 4 (TRPV4) Agonist as Regulators of Chondrogenic Differentiation. |
| 481 | 384859-58-9 | BCH001 | 2-((3-(ethoxycarbonyl)-6-(trifluoromethoxy)quinolin-4-yl)amino)benzoic acid | C20H15F3N2O5 | |
| 482 | 423145-35-1 | YUM70 | N-[1,3-Benzodioxol-5-yl(5-chloro-8-hydroxy-7-quinolinyl)methyl]butanamide | C21H19ClN2O4 | YUM70 is a potent inhibitor of GRP78 (Glucose-regulated protein, 78 kDa). YUM70, inhibited pancreatic cancer cell growth in vitro and showed in vivo efficacy in a pancreatic cancer xenograft model with no toxicity to normal tissues. YUM70 directly bound GRP78 and inactivated its function, resulting in ER stress-mediated apoptosis. A YUM70 analog conjugated with BODIPY show co-localization of the compound with GRP78 in the ER. Moreover, a YUM70-PROTAC (PROteolysis TArgeting Chimera) was synthesized to force degradation of GRP78 in pancreatic cancer cells. YUM70 showed a strong synergistic cytotoxicity with topotecan and vorinostat. |
| 483 | 1801344-12-6 | SIN44126 | SIN44126 | C24H25N7O5 | SIN44126 is a IRAK4 inhibitor, which was first described in patent WO 2015104688. This product has not formal name. For the convenience of scientific communication, we named it by combining its Inchi key (3 letters from the first letter of each section) with the last 5 digit of its CAS#) according to MedKoo Chemical Nomenclature (http://www.medkoo.com/page/medkoo_chemical_nomenclature). |
| 484 | 2138882-71-8 | KEA1-97 | KEA1-97 | C15H9Cl2FN4 | KEA1-97 is a thioredoxin-caspase 3 interaction disruptor. It has been shown to impair breast cancer pathogenicity. KEA1-97 disrupts the interaction of thioredoxin with caspase 3, activates caspases, and induces apoptosis without affecting thioredoxin activity. Moreover, KEA1-97 impairs in vivo breast tumor xenograft growth. |
| 485 | 1627138-52-6 | ML380 | ML380 | C23H25F3N4O3S | |
| 486 | 2088410-46-0 | GSK620 | 1-Benzyl-N5-cyclopropyl-N3-methyl-2-oxo-1,2-dihydropyridine-3,5-dicarboxamide | C18H19N3O3 | GSK620 is a Potent, selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitor. GSK620 showed an anti-inflammatory phenotype in human whole blood, confirming their cellular target engagement. Excellent broad selectivity, developability, and in vivo oral pharmacokinetics characterize these tools, which we hope will be of broad utility to the field of epigenetics research. |
| 487 | 2170834-63-4 | Xeruborbactam | Benzo[e]cycloprop[c][1,2]oxaborin-4-carboxylic acid, 5-fluoro-1,1a,2,7b-tetrahydro-2-hydroxy-, (1aR,7bS)- | C10H8BFO4 | QPX7728 is an ultrabroad-spectrum inhibitor of serine and metallo-β-lactamases. This compound displays a remarkably broad spectrum of inhibition, including class B and class D enzymes, and is little affected by porin modifications and efflux. QPX7728 is a promising agent for use in combination with a β-lactam antibiotic for the treatment of a wide range of multidrug resistant Gram-negative bacterial infections, by both intravenous and oral administration. |
| 488 | 1358715-18-0 | Fuzuloparib | 4-(4-fluoro-3-(2-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyrazine-7-carbonyl)benzyl)phthalazin-1(2H)-one | C22H16F4N6O2 | |
| 489 | 1800046-95-0 | Lanraplenib | 6-(6-aminopyrazin-2-yl)-N-{4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl}imidazo[1,2-a]pyrazin-8-amine | C23H25N9O | |
| 490 | 1021868-92-7 | ZM 39923 HCl | ZM 39923 HCl | C23H26ClNO | |
| 491 | 1320288-19-4 | UNC 0631 | UNC 0631 | C37H61N7O2 | |
| 492 | 1620401-82-2 | UNC0379 | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | C23H35N5O2 | |
| 493 | 136194-77-9 | Go6976 | Go6976 | C24H18N4O | |
| 494 | 1357302-64-7 | OG-L002 | OGL002 | C15H15NO | |
| 495 | 1353859-00-3 | CX-6258 | CX-6258 | C26H25Cl2N3O3 | |
| 496 | 1903008-80-9 | Lazertinib | N-{5-[(4-{4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl}pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl}prop-2-enamide | C30H34N8O3 | |
| 497 | 1219739-36-2 | ex229 (compound 991) | ex229 (compound 991) | C24H18ClN3O3 | |
| 498 | 150417-90-6 | GC7 Sulfate | GC7 Sulfate | C8H22N4O4S | |
| 499 | 1469338-01-9 | 6H05 | 6H05 | C20H30ClN3O2S3 | |
| 500 | 1899921-05-1 | 阿美替尼 | HS-10296 | C30H35N7O2 | |
| 501 | 2060530-16-5 | K-RAS(G12C)抑制剂6 | K-Ras(G12C) inhibitor 6 | C17H22Cl2N2O3S | |
| 502 | 1379545-95-5 | M2698 | M2698 | C21H19ClF3N5O | |
| 503 | 1566-81-0 | NS1652 | NS1652 | C15H11F3N2O3 | |
| 504 | 1263373-43-8 | 4-((5'-chloro-2'-((1R,4r)-4-((R)-1-methoxypropan-2-ylamino)cyclohexylamino)-2,4'-bipyridin-6-ylamino)methyl)tetrahydro-2H-pyran- | 4-((5'-chloro-2'-((1R,4r)-4-((R)-1-methoxypropan-2-ylamino)cyclohexylamino)-2,4'-bipyridin-6-ylamino)methyl)tetrahydro-2H-pyran-4-carbonitrile | C27H37ClN6O2 | |
| 505 | 11052-72-5 | 寡霉素C | OLIGOMYCIN C | C45H74O10 | |
| 506 | 1446261-44-4 | PAMIPARIB | (R)-2-fluoro-10a-methyl-7,8,9,10,10a,11-hexahydro-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(5H)-one | C16H15FN4O | |
| 507 | 497259-23-1 | TPPB | α-Amyloid Precursor Protein Modulator | C27H30F3N3O3 | 简介 TPPB是苯并内酰胺衍生的可渗透细胞的蛋白激酶C (PKC) 活化物，Ki 值为11.9 nM。 |
| 508 | 205678-31-5 | SB273005 | SB273005 | C22H24F3N3O4 | |
| 509 | 222035-13-4 | CDK2 inhibitor II | CDK2 inhibitor II | C14H11BrN4O3S | |
| 510 | 917562-33-5 | JT010 | JT010 | C16H19ClN2O3S | |
| 511 | 870964-67-3 | 伊万卡赛 | Evocalcet | C24H26N2O2 | |
| 512 | 146670-40-8 | SR 11237 | SR 11237 | C24H28O4 | |
| 513 | 895542-09-3 | Trifarotene | Trifarotene | C29 H33 N O4 | |
| 514 | 1062159-35-6 | WAY-600 | WAY-600 | C28H30N8O | |
| 515 | 1062161-90-3 | WYE-687 | WYE-687 | C28H32N8O3 | WYE-687 is a potent and ATP-competitive and selective inhibitor of mTOR with IC50 of 7 nM. |
| 516 | 1092679-51-0 | WAY-100635 Maleate | WAY-100635 Maleate | C29H38N4O6 | |
| 517 | 1139889-93-2 | Golgicide A | Golgicide A | C17H14F2N2 | |
| 518 | 1149705-71-4 | XL888 | XL888 | C29H37N5O3 | |
| 519 | 1292799-56-4 | PF-2545920 | PF-2545920 | C25H20N4O | |
| 520 | 1390637-82-7 | PF-4981517 | PF-4981517 | C26H32N8 | |
| 521 | 193000-39-4 | ZM 323881 HCl | ZM 323881 HCl | C22H19ClFN3O2 | |
| 522 | 58131-57-0 | NSC 207895 | NSC 207895 | C11H13N5O4 | |
| 523 | 819812-04-9 | KW-2478 | KW-2478 | C30H42N2O9 | |
| 524 | 1374598-80-7 | TAK-875 | TAK-875 | C58H66O15S2 | |
| 525 | 1254035-84-1 | AZD1979 | AZD1979 | C25H26N4O5 | |
| 526 | 5897-18-7 | Cyclizine 2HCl | Cyclizine 2HCl | C18H24Cl2N2 | |
| 527 | 2307249-33-6 | BAY-885 | BAY-885 | C25H28F3N7O2 | |
| 528 | 117591-20-5 | CALPEPTIN | CALPEPTIN | C20H30N2O4 | |
| 529 | 58944-73-3 | 西奈芬净 | SINEFUNGIN | C15H23N7O5 | |
| 530 | 197855-65-5 | Z-PHE-DL-ALA-FLUOROMETHYLKETONE | Z-PHE-DL-ALA-FLUOROMETHYLKETONE | C21H23FN2O4 | |
| 531 | 188968-51-6 | 西仑吉肽 | Cilengitide | C27H40N8O7 | |
| 532 | 1346546-69-7 | GSK'872 | GSK'872 | C19H17N3O2S2 | |
| 533 | 130663-39-7 | PD-123319 | PD-123319 | C31H32N4O3 | |
| 534 | 91037-75-1 | 合成线性RGD肽 | GRGDSP | C22H37N9O10 | |
| 535 | 54863-37-5 | 甲磺酰基丙氰 | Dapansutrile | C4H7NO2S | |
| 536 | 344458-19-1 | PJ34 | PJ34 | C17H17N3O2 | |
| 537 | 2183470-12-2 | GCN2iB | GCN2iB | C18H12ClF2N5O3S | |
| 538 | 154566-12-8 | SB 204990 | SB 204990 | C18H22Cl2O5 | |
| 539 | 1374040-24-0 | Furimazine | Furimazine | C24H19N3O2 | Furimazine 是一种咪唑并吡嗪酮类的发光底物。在哺乳动物细胞中， NanoLuc (Nluc) 与 Furimazine 联用，产生更亮的发光，比带 Coelenterazine 的 Oluc |
| 540 | 1256565-36-2 | 化合物PTC299 | PTC299 | C25H20Cl2N2O3 | |
| 541 | 1186649-91-1 | ML-109 | ML-109 | C31H29N3O5 | ML-109 是有效的、促甲状腺激素受体 (TSHR) 的全激动剂，其 EC50 值为 40 nM。 |
| 542 | 1660114-31-7 | NIK SMI1 | NIK SMI1 | C20H19N3O4 | |
| 543 | 2237942-08-2 | MC180295 | MC180295 | C17H18N4O3S | |
| 544 | 1352610-25-3 | EW-7197 Hydrochloride | EW-7197 Hydrochloride | C22H19ClFN7 | EW-7197 Hydrochloride is a small-molecule ATP-competitive inhibitor of TGFβRI (ALK5) with an IC50 of |
| 545 | 77465-10-2 | Adrenocorticotropic Hormone (ACTH) (1-39), rat | Adrenocorticotropic Hormone (ACTH) (1-39), rat | C210H315N57O57S1 | |
| 546 | 2095719-92-7 | ASTX-029 | ASTX-029 | C29H31ClFN5O5 | |
| 547 | 2221948-98-5 | Bis-PEG21-NHS ester | Bis-PEG21-NHS ester | C54H96N2O29 | |
| 548 | 2221948-96-3 | Bis-PEG25-NHS ester | Bis-PEG25-NHS ester | C62H112N2O33 | |
| 549 | 146478-72-0 | FR901464 | FR901464 | C27H41NO8 | |
| 550 | 2226733-37-3 | Mal-PEG24-NHS ester | Mal-PEG24-NHS ester | C62H111N3O31 | |
| 551 | 2358775-70-7 | PROTAC CRBN Degrader-1 | PROTAC CRBN Degrader-1 | C53H72N8O13S | |
| 552 | 1527475-61-1 | PFE-360 | PF-06685360 | C16H16N6O | |
| 553 | 104615-00-1 | CGS 15696 | CGS 15696 | C13H7ClN4O2 | |
| 554 | 151928-32-4 | WIN 66306 | WIN 66306 | C41H52N8O9 | |
| 555 | 127481-29-2 | L 674573 | L 674573 | C28H27NO3S | |
| 556 | 841290-81-1 | 6-[[5-氟-2-[(3,4,5-三甲氧基苯基)氨基]-4-嘧啶基]氨基]-2,2-二甲基-2H-吡啶并[3,2-B]-1,4-恶嗪-3(4H)-酮苯磺酸盐 | R406 | C28H29FN6O8S | |
| 557 | 1421783-64-3 | GZD824DIMESYLATE | GZD824 | C31H35F3N6O7S2 | |
| 558 | 1802928-88-6 | Cy3.5 Carboxylic acids | Cy3.5 Carboxylic acids | C38H41ClN2O2 | |
| 559 | 1144044-02-9 | CWP232228 | CWP232228 | C33H37N7NaO7P | |
| 560 | 1421854-16-1 | 化合物 T26537 | AC 186 | C18H17F3O | |
| 561 | 908305-13-5 | 艾培替尼 | S-22611,Epertinib | C30H27ClFN5O3 | |
| 562 | 875356-43-7 | 苏金单抗 | Secukinumab | | |
| 563 | 207732-11-4 | BB-78485 | BB-78485 | C23H20N2O4S | |
| 564 | 1688703-26-5 | Stafib-1 | Stafib-1 | C26H24N2O11P2 | |
| 565 | 1394011-91-6 | 1394011-91-6 | UC2288 | C20H18ClF6N3O2 | |
| 566 | 2380001-43-2 | Reverse transcriptase-IN-1 | Reverse transcriptase-IN-1 | C25H17N7O2 | |
| 567 | 2160546-07-4 | 4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl- | 4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl- | C17H18Cl2N6 | |
| 568 | 2170848-99-2 | 化合物 T12603 | QPX7728-OH disodium | C10H6BFNaO5- | |
| 569 | 2179128-11-9 | J52-2F/J91 | J52-2F/J91 | | |
| 570 | 870153-29-0 | 1H-Indole-2-carboxamide, N-[(1S)-1-[[[(1S)-3-hydroxy-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]propyl]amino]carbonyl]-3-methylbutyl]-4-methoxy- (9CI) | 1H-Indole-2-carboxamide, N-[(1S)-1-[[[(1S)-3-hydroxy-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]propyl]amino]carbonyl]-3-methylbutyl]-4-methoxy- (9CI) | C24H32N4O6 | |
| 571 | 2253733-11-6 | NADA-GREEN | NADA-green | C9H10ClN5O5 | |
| 572 | 2331255-53-7 | ABC99 | 4H-1,4-Benzoxazine-4-carboxylic acid, 2,3-dihydro-, 7-[(4-chlorophenyl)methyl]hexahydro-1,3-dioxoimidazo[1,5-a]pyrazin-2-yl ester | C22H21ClN4O5 | |
| 573 | 896684-04-1 | 4H-1,2,4-Benzothiadiazine-3-propanamide, 6-methyl-N-[3-(tricyclo[3.3.1.13,7]dec-1-yloxy)propyl]-, 1,1-dioxide | 4H-1,2,4-Benzothiadiazine-3-propanamide, 6-methyl-N-[3-(tricyclo[3.3.1.13,7]dec-1-yloxy)propyl]-, 1,1-dioxide | C24H33N3O4S | |
| 574 | 1952247-05-0 | 1H-Benzimidazole-5-sulfonamide, 1-[(2,4-dimethyl-5-thiazolyl)methyl]-2,3-dihydro-N-(1-methylcyclopropyl)-2-oxo-3-(1,2,4-thiadiazol-5-yl)- | 1H-Benzimidazole-5-sulfonamide, 1-[(2,4-dimethyl-5-thiazolyl)methyl]-2,3-dihydro-N-(1-methylcyclopropyl)-2-oxo-3-(1,2,4-thiadiazol-5-yl)- | C19H20N6O3S3 | |
| 575 | 1542132-88-6 | ZED-1227 | ZED-1227 | C26H36N6O6 | |
| 576 | 2381037-82-5 | RBN-2397 | (S)-5-((1-(3-oxo-3-(4-(5-(trifluoromethyl)pyrimidin-2-yl)piperazin-1-yl)propoxy)propan-2-yl)amino)-4-(trifluoromethyl)pyridazin-3(2H)-one | C20H23F6N7O3 | |
| 577 | 219861-53-7 | (R)-草酸西酞普兰 | (R)-Citalopram Oxalate | C22H23FN2O5 | |
| 578 | 149838-21-1 | PD-85639 | PD-85639 | C24H32N2O | |
| 579 | 1234365-97-9 | TENAPANOR HCL (2盐) | Tenapanor HCl | C50H68Cl6N8O10S2 | |
| 580 | 935283-04-8 | 林扎戈利 | Linzagolix | C22H15F3N2O7S | |
| 581 | 2056261-42-6 | BRD5648 | BRD5648 | C20H23N3O | |
| 582 | 2307628-67-5 | 图卡替尼N-1 | 4,6-Quinazolinediamine, N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]- | C21 H17 N7 O | |
| 583 | 1704492-14-7 | 5-Pyrimidinemethanamine, α-(4-fluorophenyl)-α-methyl-2-(1-piperazinyl)-, (αS)- | 5-Pyrimidinemethanamine, α-(4-fluorophenyl)-α-methyl-2-(1-piperazinyl)-, (αS)- | C16H20FN5 | |
| 584 | 2222094-18-8 | 化合物BC1618 | 2-Propanol, 1-[bis(phenylmethyl)amino]-3-[4-(trifluoromethyl)phenoxy]- | C24H24F3NO2 | |
| 585 | 1305116-69-1 | PF-04671536 | PF-04671536 | C14H18N8OS | |
| 586 | 2479378-45-3 | PRGL493 | PRGL493 | C25H21N7O2 | |
| 587 | 2006345-40-8 | BDP 650/665 ALKYNE | BDP 650/665 alkyne | C26H21BF2N4O2 | |
| 588 | 2102681-49-0 | SHMT-IN-2 | SHMT-IN-2 | C22H24F3N5O | |
| 589 | 2060573-82-0 | MT1 BET INHIBITOR | MT1 BET inhibitor | C54H66Cl2N10O9S2 | |
| 590 | 780771-24-6 | BBGL-2 | BbGL-2 | C43H80O10 | |
| 591 | 202284-84-2 | PHOSPHORYLATION AMIDITE | Phosphoramidous acid, bis(1-methylethyl)-, 2-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-(methylamino)-2-[(methylamino)carbonyl]-3-oxopropyl 2-cyanoethyl ester (9CI) | C37H49N4O7P | |
| 592 | 883944-52-3 | SSAA09E2 | 5-Isoxazolecarboxamide, N-[[4-(4-methyl-1-piperazinyl)phenyl]methyl]- | C16H20N4O2 | |
| 593 | 854402-59-8 | SNJ-1945 | SNJ-1945 | C25 H37 N3 O7 | |
| 594 | 2229711-08-2 | ARV-471 | ARV-471 | C45H49N5O4 | |
| 595 | 2245880-46-8 | ARX-1796 | PF-07338233 | C14H23N3O8S | |
| 596 | 2171019-55-7 | BMS-986256 | BMS-986256 | C26H32N6O | |
| 597 | 1436862-38-2 | WCK-5153 | (2S,5R)-7-oxo-2-(2-((S)-pyrrolidine-3-carbonyl)hydrazine-1-carbonyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | | |
| 598 | 929046-33-3 | N-{6-[(7S,9aS)-7-(hydroxymethyl)-octahydropyrazino[2,1-c][1,4]oxazin-8-yl]-4-(4-fluoro-2-methylphenyl)pyridin-3-yl}-2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethylpropanamide | N-{6-[(7S,9aS)-7-(hydroxymethyl)-octahydropyrazino[2,1-c][1,4]oxazin-8-yl]-4-(4-fluoro-2-methylphenyl)pyridin-3-yl}-2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethylpropanamide | C33H35F7N4O3 | |
| 599 | 2417089-74-6 | 化合物XL177A | 3-Acridinecarboxamide, 9-chloro-5,6,7,8-tetrahydro-N-[(4S)-5-[4-hydroxy-4-[[7-[[3-(4-methyl-1-piperazinyl)-1-oxopropyl]amino]-4-oxo-3(4H)-quinazolinyl]methyl]-1-piperidinyl]-5-oxo-4-(phenylmethyl)pentyl]- | C48H57ClN8O5 | |
| 600 | 2201056-66-6 | Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 3-(1-cyclohexen-1-yl)-6-(4-methoxyphenyl)-2-phenyl-5-(2-pyridinylamino)- | Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 3-(1-cyclohexen-1-yl)-6-(4-methoxyphenyl)-2-phenyl-5-(2-pyridinylamino)- | C30H27N5O2 | |
| 601 | 1570231-89-8 | APG-1387 | APG-1387 | C60H72N10O10S2 | |
| 602 | 2451862-42-1 | FREEBASE | GSK778 | C30H33N5O3 | |
| 603 | 2648641-36-3 | TPX-0131 | TPX-0131 | C21H20F3N5O3 | |
| 604 | 2569009-58-9 | Benzenesulfonamide, 2,6-dimethoxy-N-[4-methoxy-6-(1H-pyrazol-1-ylmethyl)-1,2-benzisoxazol-3-yl]- | Benzenesulfonamide, 2,6-dimethoxy-N-[4-methoxy-6-(1H-pyrazol-1-ylmethyl)-1,2-benzisoxazol-3-yl]- | C20H20N4O6S | |
| 605 | 1436862-02-0 | WCK 5153 (R) | (2S,5R)-7-oxo-2-(2-((R)-pyrrolidine-3-carbonyl)hydrazine-1-carbonyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | | |
| 606 | 1801503-93-4 | BET-IN-4 | BET-IN-4 | C22H21N3O3 | |
| 607 | 2364554-48-1 | AFICAMTEN | 1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl- | C18H19N5O2 | |
| 608 | 1675970-12-3 | 2,8-Diazaspiro[4.5]decane-2,3,8-tricarboxylic acid, 8-(1,1-dimethylethyl) 3-ethyl 2-(phenylmethyl) ester, (3S)- | 2,8-Diazaspiro[4.5]decane-2,3,8-tricarboxylic acid, 8-(1,1-dimethylethyl) 3-ethyl 2-(phenylmethyl) ester, (3S)- | C24H34N2O6 | |
| 609 | 1358751-06-0 | 9-(4-(环己氧基)苯基)-7-甲基-3,4-二氢吡嗪[2,1-C][1,2,4]噻二嗪-2,2-二氧化物 | Pyrazino[2,1-c][1,2,4]thiadiazine, 9-[4-(cyclohexyloxy)phenyl]-3,4-dihydro-7-methyl-, 2,2-dioxide | C19H23N3O3S | |
| 610 | 1817773-66-2 | 8-((S)-1-Cyclopropyl-ethyl)-2-(4-cyclopropyl-6-methyl-pyrimidin-5-yl)-6-[(5-methanesulfonyl-pyridin-2-ylmethyl)-amino]-8H-pteridin-7-one | 8-((S)-1-Cyclopropyl-ethyl)-2-(4-cyclopropyl-6-methyl-pyrimidin-5-yl)-6-[(5-methanesulfonyl-pyridin-2-ylmethyl)-amino]-8H-pteridin-7-one | C26H28N8O3S | |
| 611 | 2225940-48-5 | Pentanoic acid, 5-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]- | Pentanoic acid, 5-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]- | C18H19N3O6 | |
| 612 | 1436861-92-5 | 新型Β内酰胺酶抑制剂WTM-13-00 | (2S,5R)-2-(2-(L-prolyl)hydrazine-1-carbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate | | |
| 613 | 1452458-86-4 | OP-0595 | OP-0595 | C9H16N4O7S | |
| 614 | 14680-51-4 | METONITAZENE | METONITAZENE | C21H26N4O3 | |
| 615 | | BBP 398 | BBP 398 | | SHP2抑制剂-新药，可能用于晚期晚期非小细胞肺癌 |
| 616 | 1143532-39-1 | 4-氨基-N-[(1S)-1-(4-氯苯基)-3-羟基丙基]-1-(7H-吡咯并[2,3-D]嘧啶-4-基)-4-哌啶甲酰胺 | AZD5363 | C21H25ClN6O2 | |
| 617 | 2411748-50-8 | EZM0414 | EZM0414 | C22H29FN4O2 | |
| 618 | 1374639-74-3 | 吉格列汀酒石酸盐 | Gemigliptin | C22H25F8N5O8 | |
| 619 | 359714-55-9 | CAY10499 | CAY10499 | C18H17N3O5 | |
| 620 | 77408-67-4 | P18IN011 | P18IN011 | C15H12N2O5S | |
| 621 | 725715-18-4 | 化合物 T31978 | GM-608 | C36H54N12O9 | |
| 622 | 894554-89-3 | 化合物 T23977 | Deltazinone | C27H31N5O2 | |
| 623 | 1222106-43-5 | W54667 | W54667 | C13H14N2O2 | |
| 624 | 1639972-90-9 | ANT431 | ANT-431 | C9H7N3O4S2 | |
| 625 | 1413431-07-8 | CTP-656 | Deutivacaftor | C24H28N2O3 | |